Novel anti-herpes simplex activity of Chryseobacterium indologenes: Genomic and metabolomic insights

dc.AffiliationOctober University for modern sciences and Arts MSA
dc.contributor.authorMai A. Amer
dc.contributor.authorReham Wasfi
dc.contributor.authorHossam M. Ashour
dc.contributor.authorSamira M. Hamed
dc.date.accessioned2025-04-12T09:15:05Z
dc.date.available2025-04-12T09:15:05Z
dc.date.issued2025-04-03
dc.descriptionSJR 2024 0.825 Q2 H-Index 107
dc.description.abstractHerpes simplex virus (HSV) is a pathogenic virus responsible for various diseases, necessitating alternative antiviral strategies for HSV-1 treatment. Given the antiviral properties of lactic acid (LA), we screened rhizobacteria from the maize (Zea mays L.) rhizosphere for organic acid production. Among the isolates, SR50, SR126, and SR135 exhibited significant LA production, confirmed by High-Performance Liquid Chromatography (HPLC) analysis. Their antiviral efficacy against HSV-1 was evaluated by determining IC50 values and selectivity indices (SI = CC50/IC50), with SR50, SR126, and SR135 displaying SI values of 135.14, 10.74, and 2.17, respectively. SR50, identified via 16S rRNA sequencing as Chryseobacterium indologenes, was selected for further antiviral analysis. The cell-free supernatant (CFS) of SR50 demonstrated 73.3 % inhibition of viral adsorption, 60 % virucidal activity, and a 46.7 % reduction in viral replication. Metabolomic profiling using Gas ChromatographyMass Spectrometry (GC-MS) identified short- and long-chain organic fatty acids. Whole Genome Sequencing (WGS) revealed a 4,581,372 bp genome encoding diverse biosynthetic pathways, including siderophores, plant hormones, terpenoids, polyketides, and other bacterial secondary metabolites. Additionally, genes encoding lactaldehyde dehydrogenase and pyruvate dehydrogenase confirmed the presence of lactic and acetic acid biosynthesis pathways. This study presents the first report of C. indologenes SR50 exhibiting anti-HSV-1 activity, highlighting its potential as a novel antiviral resource.
dc.description.urihttps://www.scimagojr.com/journalsearch.php?q=22941&tip=sid&clean=0
dc.identifier.citationAmer, M. A., Wasfi, R., Ashour, H. M., & Hamed, S. M. (2025). Novel Anti-Herpes Simplex Activity of Chryseobacterium indologenes: Genomic and Metabolomic Insights. Microbial Pathogenesis, 107534. https://doi.org/10.1016/j.micpath.2025.107534
dc.identifier.doihttps://doi.org/10.1016/j.micpath.2025.107534
dc.identifier.otherhttps://doi.org/10.1016/j.micpath.2025.107534
dc.identifier.urihttps://repository.msa.edu.eg/handle/123456789/6377
dc.language.isoen_US
dc.publisherAcademic Press
dc.relation.ispartofseriesMicrobial Pathogenesis ; Volume 204 , July 2025 , Article number 107534
dc.subjectAntiviral
dc.subjectChryseobacterium indologenes
dc.subjectHerpes simplex virus
dc.subjectOrganic acids
dc.subjectRhizobacteria
dc.subjectZea mays ecosystem
dc.titleNovel anti-herpes simplex activity of Chryseobacterium indologenes: Genomic and metabolomic insights
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
1-s2.0-S0882401025002591-main.pdf
Size:
8.23 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
51 B
Format:
Item-specific license agreed upon to submission
Description: